Sponsors (58)
Introduced March 26, 2025 by Joseph Morelle · Last progress March 26, 2025
The bill expands and funds a national breast and cervical cancer screening program to improve access, quality, and data for policymakers—benefiting low-income and uninsured women—but it increases federal spending, may constrain local flexibility through narrowly defined evidence requirements, and will require administrative scaling that could limit near-term gains.
Low-income, uninsured, and underinsured women will gain increased access to breast and cervical cancer screening, diagnostic services, and earlier detection through reauthorization and program expansion.
Provides predictable federal funding ($235 million per year for FY2026–2030) to support program operations and continuity of screening services for states and health systems.
Adds outreach, patient navigation, and evidence-based strategies to reduce barriers and increase screening uptake, improving access for geographically or culturally isolated and low-income populations.
Higher federal spending to reauthorize and expand the program (including $235M/year) increases taxpayer obligations or requires trade-offs with other budget priorities.
Tying services narrowly to specific 'evidence-based recommendations' could limit local program flexibility and leave underrepresented or atypical populations without appropriate services.
Expanding the program may strain existing provider networks and require administrative scaling, causing implementation delays or reduced service capacity in some areas.
Based on analysis of 4 sections of legislative text.
Reauthorizes and updates the federal breast and cervical cancer screening program, expands equity and navigation activities, requires evidence-based services, and authorizes $235M/year for FY2026–2030.
Reauthorizes and updates the National Breast and Cervical Cancer Early Detection Program to broaden program goals, strengthen requirements for evidence-based screening and follow-up, and add emphasis on patient navigation, outreach, and reducing access disparities. It authorizes $235,000,000 per year for fiscal years 2026–2030 and requires a Comptroller General report by September 30, 2027, on eligibility, trends in people served, and barriers to screening under the program.